Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Video AMP 2023

Value of Alternative Access for Treatment of Multilevel and Multivessel Disease

Fadi A. Saab, MD, FASE, FACC, FSCAI

Advanced Cardiac and Vascular Centers, Grand Rapids, Michigan

06/28/2023

In this case, the common nature of CLTI patients with multivessel, multilevel disease and multiple comorbidities is well demonstrated. The use of strategies to reduce contrast and radiation exposure for these patients is very important for success of revascularization. This case highlights the use of these technologies and the importance of staging patients with complex CLI disease.

Join us at the 2023 Amputation Prevention Symposium (AMP), taking place August 16-19 in Chicago, to see similar complex cases performed live by expert operators.


Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Intravascular Lithotripsy
Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter
09/16/2024
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI).  
The Shockwave E8 catheter is...
09/16/2024
Cath Lab Digest
News
Argon Medical Launches CLEANER Vac™ Thrombectomy System to Remove Blood Clot in the Peripheral Venous Vasculature
09/16/2024
PLANO, Texas, Sept. 16, 2024 /PRNewswire/ -- Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the...
PLANO, Texas, Sept. 16, 2024 /PRNewswire/ -- Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the...
PLANO, Texas, Sept. 16, 2024...
09/16/2024
Vascular Disease Management
Aneurysms
Study: Why Aortic Aneurysms Form at the Arch or in the Abdominal Segment
08/20/2024
In order to find out what distinguishes the repeatedly affected vascular regions from others, Daniela Wenzel and her team developed a method to specifically examine the endothelium of the aorta. “We know from other vascular diseases such as...
In order to find out what distinguishes the repeatedly affected vascular regions from others, Daniela Wenzel and her team developed a method to specifically examine the endothelium of the aorta. “We know from other vascular diseases such as...
In order to find out what...
08/20/2024
Cath Lab Digest
News
AVS Partners with the Jacobs Institute to Expedite Clinical Trials for Coronary and Carotid Indications
08/20/2024
Company’s agreement with the JI demonstrates progress toward commercialization of Pulse IVL™ Intravascular Lithotripsy System August 20, 2024--BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on...
Company’s agreement with the JI demonstrates progress toward commercialization of Pulse IVL™ Intravascular Lithotripsy System August 20, 2024--BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company focused on...
Company’s agreement with the JI...
08/20/2024
Vascular Disease Management
Vascular Closure
Haemonetics Announces Full Market Release for Vascade MVP XL Vascular Closure System
08/15/2024
The VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch...
The VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch...
The VASCADE MVP XL system is now...
08/15/2024
Cath Lab Digest
Pulmonary Embolism
Jupiter Endovascular Announces $21M in New Financing to Fund Pivotal Trial for Pulmonary Embolism
08/15/2024
Jupiter Endovascular is developing the endoportal procedure, using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates...
Jupiter Endovascular is developing the endoportal procedure, using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates...
Jupiter Endovascular is...
08/15/2024
Cath Lab Digest
News
CIS & Terrebonne General Are First in Louisiana to Use New Triclip™ Valve Repair System
08/12/2024
August 9, 2024 - HOUMA, LA – Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the TriClip™ G4 Transcatheter Edge-to-Edge Repair System to treat severe tricuspid regurgitation. Drs. Peter Fail, Shane Prejean...
August 9, 2024 - HOUMA, LA – Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the TriClip™ G4 Transcatheter Edge-to-Edge Repair System to treat severe tricuspid regurgitation. Drs. Peter Fail, Shane Prejean...
August 9, 2024 - HOUMA, LA...
08/12/2024
Vascular Disease Management
Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement